# Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

> **NCT01672151** · — · COMPLETED · sponsor: **First Affiliated Hospital of Suzhou Medical College** · enrollment: 35 (actual)

## Conditions studied

- Immune Thrombocytopenic Purpura

## Interventions

- **DRUG:** rapamycin

## Key facts

- **NCT ID:** NCT01672151
- **Lead sponsor:** First Affiliated Hospital of Suzhou Medical College
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2012-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01672151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01672151, "Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01672151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*